Feasibility of Computed Tomography in a Multicenter COPD Trial: A Study of the Effect of AZD9668 on Structural Airway Changes
Conclusions
This study confirmed the feasibility of using CT to assess structural airway changes in COPD. However, there was no evidence of improvements in CT structural measures following 12 weeks’ treatment with AZD9668 60 mg BID.
Funding
AstraZeneca.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: AstraZeneca | Chronic Obstructive Pulmonary | Cough | CT Scan | Drugs & Pharmacology | Respiratory Medicine | Smokers | Study